Skip to content

In the BioHarmony Drug Report Database

Niacin

Niaspan, Niaspan Titration Starter Pack, Wampocap (niacin) is a small molecule pharmaceutical. Niacin was first approved as Niaspan on 1982-01-01. It is used to treat hypercholesterolemia, hypertriglyceridemia, pellagra, and peripheral vascular diseases in the USA. It is known to target hydroxycarboxylic acid receptor 3, hydroxycarboxylic acid receptor 2, hydroxycarboxylic acid receptor 1, and carbonic anhydrase 2.
Trade Name Niaspan, Niaspan Titration Starter Pack, Wampocap
Common Name Niacin
Indication hypercholesterolemia, hypertriglyceridemia, pellagra, peripheral vascular diseases
Drug Class
Niacin
Get full access now